Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids
Cross-sectional observational survey (n=102 actual responses to date) collecting insights from first responders and military personnel on need for, use of, and interest in medical marijuana or psychedelic-assisted therapy programmes.
Detailed Description
The primary objective is to collect insights from first responders and military personnel on their need for, use of, and interest in physical and/or mental health medical marijuana or psychedelic-assisted therapy programmes to inform larger patient-oriented studies and clinical programme design.
Participants are recruited via unions and representative organisations across Canada, the United States, Oceana (notably Australia and New Zealand) and Europe (including the United Kingdom); sampling is non-probability and the investigators expect a modest response rate from a large invited cohort.
Study Arms & Interventions
North American First Responders
experimentalFirst responders in Canada and the United States invited via union representatives to complete a survey; subgroup for cannabis use data.
Interventions
- Compoundvia Other• survey
Cannabis (recreational) use queried — observational survey data only.
Oceana & European First Responders
experimentalFirst responders in Oceana and Europe (including Australia, New Zealand, UK) invited via unions; cannabis use queried.
Interventions
- Compoundvia Other• survey
Cannabis (recreational) use queried — observational survey data only.
Participants
Inclusion Criteria
- Inclusion Criteria:
- Adult (19+) first responders and military personnel in Canada, USA, Oceana and Europe
- Not restricted by sex, gender, or diagnoses
- Respondents must be able to read and write in English to participate.
- Exclusion Criteria:
- Individuals who are not first responders, military personnel, or an aligned profession
- Individuals under the age of 19
- Those who are not able to read and write in English
Exclusion Criteria
No exclusion criteria listed.
Study Details
- StatusCompleted
- PhasePhase NA
- Typeobservational
- DesignNon-randomized
- Target Enrollment102 participants
- TimelineStart: 2021-06-04End: 2021-12-30
- Topic